Cineplex Inc.
CPXGF
$6.76
-$0.059-0.87%
| Weiss Ratings | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | D+ | |||
| Rating Factors | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Fair | |||
| Solvency Index | Fair | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.95 | |||
| Price History | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.57% | |||
| 30-Day Total Return | -11.85% | |||
| 60-Day Total Return | -25.02% | |||
| 90-Day Total Return | -9.85% | |||
| Year to Date Total Return | -19.80% | |||
| 1-Year Total Return | 19.96% | |||
| 2-Year Total Return | 17.40% | |||
| 3-Year Total Return | -31.71% | |||
| 5-Year Total Return | -61.63% | |||
| 52-Week High % Change | -26.85% | |||
| 52-Week Low % Change | 30.90% | |||
| Price | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.32 | |||
| 52-Week Low Price | $5.21 | |||
| 52-Week Low Price (Date) | Jun 20, 2024 | |||
| 52-Week High Price (Date) | Dec 26, 2024 | |||
| Valuation | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 428.34M | |||
| Enterprise Value | 1.64B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.44 | |||
| Earnings Per Share Growth | -132.84% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.44 | |||
| Price/Book (Q) | -15.68 | |||
| Enterprise Value/Revenue (TTM) | 1.69 | |||
| Price | $6.76 | |||
| Enterprise Value/EBITDA (TTM) | 13.14 | |||
| Enterprise Value/EBIT | 25.76 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 63.32M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.11 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | $0.11 | |||
| Company Info | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 1303 Yonge Street Toronto, ON M4T 2Y9 | |||
| Website | www.cineplex.com | |||
| Country | Canada | |||
| Year Founded | 1912 | |||
| Profitability | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 6.56% | |||
| Profit Margin | -2.84% | |||
| Management Effectiveness | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 2.41% | |||
| Return on Equity | -- | |||
| Income Statement | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 913.03M | |||
| Total Revenue (TTM) | 970.49M | |||
| Revenue Per Share | $15.33 | |||
| Gross Profit (TTM) | 634.89M | |||
| EBITDA (TTM) | 124.92M | |||
| EBIT (TTM) | 63.73M | |||
| Net Income (TTM) | -27.59M | |||
| Net Income Avl. to Common (TTM) | -27.59M | |||
| Total Revenue Growth (Q YOY) | 11.89% | |||
| Earnings Growth (Q YOY) | 126.76% | |||
| EPS Diluted (TTM) | -0.44 | |||
| EPS Diluted Growth (Q YOY) | 136.26% | |||
| Balance Sheet | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 58.29M | |||
| Cash Per Share (Q) | $0.92 | |||
| Total Current Assets (Q) | 165.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -27.59M | |||
| Current Ratio (Q) | 0.429 | |||
| Book Value Per Share (Q) | -$0.44 | |||
| Total Assets (Q) | 1.59B | |||
| Total Current Liabilities (Q) | 385.43M | |||
| Total Debt (Q) | 1.28B | |||
| Total Liabilities (Q) | 1.62B | |||
| Total Common Equity (Q) | -27.59M | |||
| Cash Flow | CPXGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 52.81M | |||
| Cash from Financing (TTM) | -136.00M | |||
| Net Change in Cash (TTM) | 34.19M | |||
| Levered Free Cash Flow (TTM) | 159.89M | |||
| Cash from Operations (TTM) | 117.13M | |||
